{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:15:13Z","timestamp":1792120513082,"version":"4.4.0"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Bioeng. Biotechnol."],"abstract":"<jats:p>The quantification of lentiviral vector (LVV) potency via titration is a critical quality control step for cell and gene therapies. However, standard functional titre assays are fundamentally limited by an inability to detect multiple integration events, procedural variations, and, most critically, a mass transport limitation created by the fluid overlay in conventional well plates. These issues, compounded by a lack of standardisation, lead to significant inter-laboratory variability and a systematic underestimation of true vector potency. In this study, we employed a microfluidic approach to create a more precisely engineered assay environment. We systematically evaluated channel depth, incubation time, vector concentration, and multiplicity of infection (MOI) for their impact on assay linearity, sensitivity, limit of detection, and reproducibility. A 0.2 mm deep channel provided linearity and reproducibility comparable to 96-well plates yet offered shorter incubation periods, and enhanced sensitivity, detecting activity down to a MOI of 0.0625 (corroborated by qPCR analysis) - a level at which conventional well plates fail. This establishes our microfluidic platform as a device-based analytical standard that transforms functional titre quantification from a variable protocol into a more reliable engineering solution for quality testing in cell therapy manufacturing.<\/jats:p>","DOI":"10.3389\/fbioe.2026.1720882","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T05:48:28Z","timestamp":1776059308000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Rethinking viral vector quantification: a microfluidic approach to standardised functional titre assays"],"prefix":"10.3389","volume":"14","author":[{"given":"Daria Andreea","family":"Farcas","sequence":"first","affiliation":[{"name":"Department of Biochemical Engineering, University College London","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Moore-Kelly","sequence":"additional","affiliation":[{"name":"Oxford Biomedica (UK) Limited","place":["Oxford, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippa","family":"Stevenson","sequence":"additional","affiliation":[{"name":"Department of Biochemical Engineering, University College London","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui Andr\u00e9 Saraiva","family":"Raposo","sequence":"additional","affiliation":[{"name":"Oxford Biomedica (UK) Limited","place":["Oxford, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco P. C.","family":"Marques","sequence":"additional","affiliation":[{"name":"Department of Biochemical Engineering, University College London","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Szita","sequence":"additional","affiliation":[{"name":"Department of Biochemical Engineering, University College London","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2200053","DOI":"10.1002\/mame.202200053","article-title":"A review of cyclic olefin copolymer applications in microfluidics and microdevices","volume":"307","author":"Agha","year":"2022","journal-title":"Macromol. Mater. Eng."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e202300116","DOI":"10.1002\/appl.202300116","article-title":"Enhancing fabrication of hybrid microfluidic devices through silane-based bonding: a focus on polydimethylsiloxane-cyclic olefin copolymer and PDMS-Lithium niobate","volume":"3","author":"Agha","year":"2024","journal-title":"Appl. Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e00792","DOI":"10.1016\/j.btre.2023.e00792","article-title":"A straightforward microfluidic-based approach toward optimizing transduction efficiency of HIV-1-derived lentiviral vectors in BCP-ALL cells","volume":"38","author":"Ahmadi","year":"2023","journal-title":"Biotechnol. Rep."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1128\/jvi.74.3.1258-1266.2000","article-title":"Toward a more accurate quantitation of the activity of recombinant retroviruses: alternatives to titer and multiplicity of infection","volume":"74","author":"Andreadis","year":"2000","journal-title":"J. Virology"},{"key":"B5","first-page":"101","article-title":"Microfluidic devices as process development tools for cellular therapy manufacturing","volume-title":"Microfluidics in biotechnology","author":"Aranda Hernandez","year":"2022"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.trac.2024.118004","article-title":"A review on recent advances of AI-integrated microfluidics for analytical and bioanalytical applications","volume":"181","author":"Asadian","year":"2024","journal-title":"TrAC - Trends Anal. Chem."},{"key":"B7","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1002\/jbm.a.36199","article-title":"Biocompatibility assessment of cyclic olefin copolymers: impact of two additives on cytotoxicity, oxidative stress, inflammatory reactions, and hemocompatibility","volume":"105","author":"Bernard","year":"2017","journal-title":"J. Biomed. Mater. Res. - Part A"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2478\/raon-2022-0002","article-title":"Cancer gene therapy goes viral: viral vector platforms come of age","volume":"56","author":"Bezeljak","year":"2022","journal-title":"Radiology Oncol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.omtm.2023.02.013","article-title":"Generation of packaging cells for lentiviral vectors using the cumate and coumermycin gene induction systems and nanowell based single-cell cloning","volume":"29","author":"Broussau","year":"2023","journal-title":"Mol. Ther. - Methods and Clin. Dev."},{"key":"B11","volume-title":"Cell and gene therapy catapult UK ATMP clinical trials report 2022","year":"2022"},{"key":"B12","article-title":"Cell and Gene therapies: looking ahead to 2022","volume-title":"Milken Institute","author":"Choe","year":"2022"},{"key":"B13","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1089\/hum.1996.7.6-743","article-title":"Consistent and high rates of gene transfer can be obtained using flow-through transduction over a wide range of retroviral titers","volume":"7","author":"Chuck","year":"1996","journal-title":"Hum. Gene Ther."},{"key":"B14","doi-asserted-by":"publisher","first-page":"107868","DOI":"10.1016\/j.bej.2020.107868","article-title":"Lentiviral vector bioprocess economics for cell and gene therapy commercialization","volume":"167","author":"Comisel","year":"2021","journal-title":"Biochem. Eng. J."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/j.snb.2011.07.040","article-title":"Characterisation of an irreversible bonding process for COC-COC and COC-PDMS-COC sandwich structures and application to microvalves","volume":"160","author":"Cortese","year":"2011","journal-title":"Sensors Actuators, B Chem."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06524-0","article-title":"Optimizing viral transduction in immune cell therapy manufacturing: key process design considerations","volume":"23","author":"Dan","year":"2025","journal-title":"J. Transl. Med."},{"key":"B17","article-title":"Guidance for industry: potency tests for cellular and gene therapy products","year":"2011"},{"key":"B18","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.ccell.2025.03.019","article-title":"CAR-T therapy in solid tumors","volume":"43","author":"Du","year":"2025","journal-title":"Cancer Cell"},{"key":"B19","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1084\/jem.99.2.167","article-title":"Plaque formation and isolation of pure lines with poliomyelitis viruses","volume":"99","author":"Dulbecco","year":"1954","journal-title":"J. Exp. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"8463","DOI":"10.1128\/JVI.72.11.8463-8471.1998","article-title":"A third-generation lentivirus vector with a conditional packaging system","volume":"72","author":"Dull","year":"1998","journal-title":"J. Virology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1472-6750-6-34","article-title":"Comparison of lentiviral vector titration methods","volume":"6","author":"Geraerts","year":"2006","journal-title":"BMC Biotechnol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"110276","DOI":"10.1016\/j.biopha.2020.110276","article-title":"Concise review on optimized methods in production and transduction of lentiviral vectors in order to facilitate immunotherapy and gene therapy","volume":"128","author":"Gouvarchin Ghaleh","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2300308","DOI":"10.1002\/adpr.202300308","article-title":"From pixels to information: artificial intelligence in Fluorescence Microscopy","volume":"5","author":"Han","year":"2024","journal-title":"Adv. Photonics Res."},{"key":"B24","volume-title":"Using a microfluidic approach to test for critical quality attributes of viral vectors for gene therapy applications","author":"Harvey","year":"2023"},{"key":"B25","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1006\/viro.2000.0743","article-title":"Kinetic analyses of stability of simple and complex retroviral vectors","volume":"280","author":"Higashikawa","year":"2001","journal-title":"Virology"},{"key":"B26","volume-title":"Analyzing single-use polymers for cell culture processes comparison of cell growth and viability Test procedures","author":"Kneitz","year":"2022"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e0254739","DOI":"10.1371\/journal.pone.0254739","article-title":"Infectious titer determination of lentiviral vectors using a temporal immunological real-time imaging approach","volume":"16","author":"Labisch","year":"2021","journal-title":"PLoS ONE"},{"key":"B28","doi-asserted-by":"publisher","first-page":"663","DOI":"10.18609\/cgti.2016.073","article-title":"Understanding and managing sources of variability in cell measurements","volume":"2","author":"Lin-Gibson","year":"2016","journal-title":"Cell Gene Ther. Insights"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.12665\/J24OA","article-title":"Large-scale production and purification of a lentiviral vector reference material","volume":"24","author":"Manceur","year":"2025","journal-title":"BioProcessing J."},{"key":"B29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jbiotec.2016.10.016","article-title":"Challenges of up-scaling lentivirus production and processing","volume":"240","author":"McCarron","year":"2016","journal-title":"J. Biotechnol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"16017","DOI":"10.1038\/mtm.2016.17","article-title":"Production of lentiviral vectors","volume":"3","author":"Merten","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/jfb13010002","article-title":"Properties and applications of PDMS for biomedical engineering: a review","volume":"13","author":"Miranda","year":"2022","journal-title":"J. Funct. Biomaterials"},{"key":"B32","doi-asserted-by":"publisher","first-page":"15101","DOI":"10.1038\/s41598-019-50981-9","article-title":"A microfluidic device to enhance viral transduction efficiency during manufacture of engineered cellular therapies","volume":"9","author":"Moore","year":"2019","journal-title":"Sci. Rep."},{"key":"B33","first-page":"263","article-title":"In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector","volume-title":"Science","author":"Naldini","year":"1996"},{"key":"B34","doi-asserted-by":"crossref","unstructured":"Sensitivity and reproducibility in adenoviral infectious titer determination\n          \n          808\n          811\n          \n            \n              Nyberg-Hoffman\n              C.\n            \n            \n              Shabram\n              P. L.\n            \n            \n              Li\n              W.\n            \n            \n              Giroux\n              D.\n            \n          \n          10.1038\/nm0797-808\n          9212113\n          Mol. Ther.\n          3\n          1997","DOI":"10.1038\/nm0797-808"},{"key":"B35","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3390\/v13020268","article-title":"Lentiviral vector bioprocessing","volume":"13","author":"Perry","year":"2021","journal-title":"Viruses"},{"key":"B36","doi-asserted-by":"publisher","first-page":"107603","DOI":"10.1016\/j.pharmthera.2020.107603","article-title":"Genetically modified immune cells targeting tumor antigens","volume":"214","author":"Poorebrahim","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1177\/24725552211039754","article-title":"Treating cells as reagents to design reproducible assays","volume":"26","author":"Riss","year":"2021","journal-title":"SLAS Discov."},{"key":"B38","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1006\/mthe.2000.0212","article-title":"Multiplicity of infection\/multiplicity of confusion","volume":"2","author":"Shabram","year":"2000","journal-title":"Mol. Ther."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1002\/jssc.202100937","article-title":"Clinical grade lentiviral vector purification and quality control requirements","volume":"45","author":"Shi","year":"2022","journal-title":"J. Sep. Sci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/sj.gt.3302570","article-title":"Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors - design, biosafety, and production","volume":"12","author":"Sinn","year":"2005","journal-title":"Gene Ther."},{"key":"B51","unstructured":"Useful Numbers for Cell Culture\n          \n          \n          2006"},{"key":"B41","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3390\/inventions3030065","article-title":"Pdms-based microfluidic devices for cell culture","volume":"3","author":"Torino","year":"2018","journal-title":"MDPI Multidiscip. Digit. Publ. Inst."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1016\/j.ymthe.2017.07.002","article-title":"Microfluidic transduction harnesses mass transport principles to enhance gene transfer efficiency","volume":"25","author":"Tran","year":"2017","journal-title":"Mol. Ther."},{"key":"B43","doi-asserted-by":"publisher","first-page":"101315","DOI":"10.1016\/j.omtm.2024.101315","article-title":"Lentiviral vector packaging and producer cell lines yield titers equivalent to the industry-standard four-plasmid process","volume":"32","author":"Tridgett","year":"2024","journal-title":"Mol. Ther. - Methods and Clin. Dev."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.865424","article-title":"Review: sustainable clinical development of CAR-T cells - switching from viral transduction towards CRISPR-Cas gene editing","volume":"13","author":"Wagner","year":"2022","journal-title":"Front. Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.1002\/bit.28834","article-title":"Auto-transduction in lentiviral vector bioprocessing: a quantitative assessment and a novel inhibition strategy","volume":"121","author":"Williams-Fegredo","year":"","journal-title":"Biotechnol. Bioeng."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1409203","DOI":"10.3389\/fbioe.2024.1409203","article-title":"Degradation of specific glycosaminoglycans improves transfection efficiency and vector production in transient lentiviral vector manufacturing processes","volume":"12","author":"Williams-Fegredo","year":"","journal-title":"Front. Bioeng. Biotechnol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/cyto.b.21108","article-title":"Validation of cell-based fluorescence assays: Practice guidelines from the ICSH and ICCS - Part v - performance criteria","volume":"84","author":"Wood","year":"2013","journal-title":"Cytometry. Part B, Clinical Cytometry"},{"key":"B47","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1186\/s12967-025-06438-x","article-title":"Therapeutic effect of miR-30b-5p-loaded lentivirus on experimental autoimmune uveitis via inhibiting Notch signaling activation","volume":"23","author":"Yin","year":"2025","journal-title":"J. Transl. Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/cyto.a.24796","article-title":"Optimization and validation of in vivo flow cytometry chimeric antigen receptor T cell detection method using CD19his indirect staining","volume":"105","author":"Zaninelli","year":"2024","journal-title":"Cytom. Part A"}],"container-title":["Frontiers in Bioengineering and Biotechnology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbioe.2026.1720882\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T05:48:34Z","timestamp":1776059314000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbioe.2026.1720882\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":50,"alternative-id":["10.3389\/fbioe.2026.1720882"],"URL":"https:\/\/doi.org\/10.3389\/fbioe.2026.1720882","relation":{},"ISSN":["2296-4185"],"issn-type":[{"value":"2296-4185","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"article-number":"1720882"}}